CIBC Private Wealth Group’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,000
Closed -$129 1189
2023
Q3
$129 Hold
10,000
﹤0.01% 1077
2023
Q2
$1.52K Hold
10,000
﹤0.01% 876
2023
Q1
$1.44K Hold
10,000
﹤0.01% 886
2022
Q4
$1 Hold
10,000
﹤0.01% 859
2022
Q3
$2K Hold
10,000
﹤0.01% 908
2022
Q2
$18K Hold
10,000
﹤0.01% 1034
2022
Q1
$30K Hold
10,000
﹤0.01% 1072
2021
Q4
$37K Hold
10,000
﹤0.01% 1003
2021
Q3
$59K Hold
10,000
﹤0.01% 919
2021
Q2
$174K Hold
10,000
﹤0.01% 1002
2021
Q1
$191K Hold
10,000
﹤0.01% 999
2020
Q4
$175K Buy
+10,000
New +$120K ﹤0.01% 953

Other funds holding HGEN

CIBC Private Wealth Group's HGEN Position: Q4 2023 in Review

CIBC Private Wealth Group sold out of HUMANIGEN, INC. (HGEN) in Q4 2023, closing a stake of 10,000 shares — an estimated $129 sold.

CIBC Private Wealth Group first reported a position in HGEN in Q4 2020 and held it in 12 quarters. The position peaked at $191K in Q1 2021. 1 fund tracked by Wall St. Rank holds HGEN as of Q4 2023.

  • CIBC Private Wealth Group reported no remaining HUMANIGEN, INC. position as of Q4 2023 after selling out during the quarter.
  • CIBC Private Wealth Group sold 10,000 HUMANIGEN, INC. shares in Q4 2023, an estimated $129.
  • CIBC Private Wealth Group first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 12 quarters.
  • CIBC Private Wealth Group's HUMANIGEN, INC. position peaked at $191K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held HUMANIGEN, INC. as of Q4 2023.

Based on CIBC Private Wealth Group's 13F filing for Q4 2023, filed 13 Feb 2024.